{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T05:19:43Z","timestamp":1780377583902,"version":"3.54.1"},"reference-count":49,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,9,15]],"date-time":"2022-09-15T00:00:00Z","timestamp":1663200000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinical-colorectal-cancer.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Colorectal Cancer"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.clcc.2022.09.002","type":"journal-article","created":{"date-parts":[[2022,9,19]],"date-time":"2022-09-19T22:34:34Z","timestamp":1663626874000},"page":"285-296","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Prognostic Factors for Effectiveness Outcomes After Transarterial Radioembolization in Metastatic Colorectal Cancer: Results From the Multicentre Observational Study CIRT"],"prefix":"10.1016","volume":"21","author":[{"given":"Niklaus","family":"Schaefer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerd","family":"Gr\u00f6zinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maciej","family":"Pech","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Pfammatter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cigdem","family":"Soydal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirk","family":"Arnold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Kolligs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geert","family":"Maleux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graham","family":"Munneke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bora","family":"Peynircioglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Sangro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helena","family":"Pereira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bleranda","family":"Zeka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2377-2973","authenticated-orcid":false,"given":"Niels","family":"de Jong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Helmberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clcc.2022.09.002_bib0001","first-page":"209","article-title":"Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.clcc.2022.09.002_bib0002","first-page":"20","article-title":"New paradigm in the management of liver-only metastases from colorectal cancer","volume":"1","author":"Donadon","year":"2007","journal-title":"Gastrointest Cancer Res"},{"key":"10.1016\/j.clcc.2022.09.002_bib0003","doi-asserted-by":"crossref","first-page":"6113","DOI":"10.3748\/wjg.v20.i20.6113","article-title":"Role of surgery in colorectal cancer liver metastases","volume":"20","author":"Akgul","year":"2014","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.clcc.2022.09.002_bib0004","doi-asserted-by":"crossref","first-page":"329","DOI":"10.6004\/jnccn.2021.0012","article-title":"Colon Cancer, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology","volume":"19","author":"Benson","year":"2021","journal-title":"J Natl Compr Canc Netw"},{"key":"10.1016\/j.clcc.2022.09.002_bib0005","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1093\/annonc\/mdw235","article-title":"ESMO consensus guidelines for the management of patients with metastatic colorectal cancer","volume":"27","author":"Van Cutsem","year":"2016","journal-title":"Ann Oncol"},{"key":"10.1016\/j.clcc.2022.09.002_bib0006","first-page":"129","article-title":"The role of liver-directed therapy in metastatic colorectal cancer","volume":"14","author":"Tan","year":"2018","journal-title":"Curr Colorectal Cancer Rep"},{"key":"10.1016\/j.clcc.2022.09.002_bib0007","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1097\/COC.0000000000000898","article-title":"Yttrium-90 Radioembolization of Colorectal Cancer Liver Metastases: a Systematic Review of Clinical Evidence","volume":"45","author":"d'Andrea","year":"2022","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.clcc.2022.09.002_bib0008","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1097\/COC.0b013e3181f47583","article-title":"Radioembolization for the treatment of liver tumors general principles","volume":"35","author":"Kennedy","year":"2012","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.clcc.2022.09.002_bib0009","doi-asserted-by":"crossref","first-page":"302","DOI":"10.6004\/jnccn.2019.0019","article-title":"Guidelines insights: hepatobiliary cancers, Version 2.2019","volume":"17","author":"Benson","year":"2019","journal-title":"J Natl Compr Canc Netw"},{"key":"10.1016\/j.clcc.2022.09.002_bib0010","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.jhep.2018.03.019","article-title":"European Association for the Study of the Liver. Electronic address eee, European Association for the Study of the L. EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma","volume":"69","year":"2018","journal-title":"J Hepatol"},{"issue":"suppl 5","key":"10.1016\/j.clcc.2022.09.002_bib0011","doi-asserted-by":"crossref","first-page":"v28","DOI":"10.1093\/annonc\/mdw324","article-title":"Biliary cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"27","author":"Valle","year":"2016","journal-title":"Ann Oncol"},{"issue":"6","key":"10.1016\/j.clcc.2022.09.002_bib0012","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/cancers13061371","article-title":"Review of intra-arterial therapies for colorectal cancer liver metastasis","volume":"13","author":"Kwan","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.clcc.2022.09.002_bib0013","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1023\/A:1013569329846","article-title":"Randomised trial of SIR-Spheres plus chemotherapy vs. chemotherapy alone for treating patients with liver metastases from primary large bowel cancer","volume":"12","author":"Gray","year":"2001","journal-title":"Ann Oncol"},{"issue":"23","key":"10.1016\/j.clcc.2022.09.002_bib0014","doi-asserted-by":"crossref","first-page":"3687","DOI":"10.1200\/JCO.2010.28.5643","article-title":"Phase III trial comparing protracted intravenous fluorouracil infusion alone or with yttrium-90 resin microspheres radioembolization for liver-limited metastatic colorectal cancer refractory to standard chemotherapy","volume":"28","author":"Hendlisz","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clcc.2022.09.002_bib0015","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1002\/jso.20141","article-title":"Randomised phase 2 trial of SIR-Spheres plus fluorouracil\/leucovorin chemotherapy versus fluorouracil\/leucovorin chemotherapy alone in advanced colorectal cancer","volume":"88","author":"Van Hazel","year":"2004","journal-title":"J Surg Oncol"},{"key":"10.1016\/j.clcc.2022.09.002_bib0016","doi-asserted-by":"crossref","first-page":"265","DOI":"10.2217\/hep.14.6","article-title":"SIR-Spheres yttrium-90 radioembolization for the treatment of unresectable liver cancers","volume":"1","author":"Golfieri","year":"2014","journal-title":"Hepat Oncol"},{"key":"10.1016\/j.clcc.2022.09.002_bib0017","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1002\/cncr.24224","article-title":"Radioembolization of colorectal hepatic metastases using yttrium-90 microspheres","volume":"115","author":"Mulcahy","year":"2009","journal-title":"Cancer"},{"key":"10.1016\/j.clcc.2022.09.002_bib0018","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1200\/JCO.2015.66.1181","article-title":"SIRFLOX: Randomized Phase III trial comparing first-line mFOLFOX6 (Plus or Minus Bevacizumab) Versus mFOLFOX6 (Plus or Minus Bevacizumab) plus selective internal radiation therapy in patients with metastatic colorectal cancer","volume":"34","author":"van Hazel","year":"2016","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clcc.2022.09.002_bib0019","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1016\/S1470-2045(17)30457-6","article-title":"First-line selective internal radiotherapy plus chemotherapy versus chemotherapy alone in patients with liver metastases from colorectal cancer (FOXFIRE, SIRFLOX, and FOXFIRE-Global): a combined analysis of three multicentre, randomised, phase 3 trials","volume":"18","author":"Wasan","year":"2017","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.clcc.2022.09.002_bib0020","doi-asserted-by":"crossref","first-page":"3897","DOI":"10.1200\/JCO.21.01839","article-title":"Radioembolization with chemotherapy for colorectal liver metastases: a randomized, open-label, international, multicenter, phase III trial","volume":"39","author":"Mulcahy","year":"2021","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clcc.2022.09.002_bib0021","doi-asserted-by":"crossref","first-page":"e16296","DOI":"10.2196\/16296","article-title":"Clinical application of radioembolization in hepatic malignancies: protocol for a prospective multicenter observational study","volume":"9","author":"Helmberger","year":"2020","journal-title":"JMIR Res Protoc"},{"key":"10.1016\/j.clcc.2022.09.002_bib0022","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s00270-020-02642-y","article-title":"Clinical application of trans-arterial radioembolization in hepatic malignancies in europe: first results from the prospective multicentre observational study CIRSE registry for SIR-Spheres Therapy (CIRT)","volume":"44","author":"Helmberger","year":"2021","journal-title":"Cardiovasc Intervent Radiol"},{"key":"10.1016\/j.clcc.2022.09.002_bib0023","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1245\/s10434-018-07125-6","article-title":"The combination of APRI and ALBI facilitates preoperative risk stratification for patients undergoing liver surgery after neoadjuvant chemotherapy","volume":"26","author":"Pereyra","year":"2019","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"10.1016\/j.clcc.2022.09.002_bib0024","doi-asserted-by":"crossref","first-page":"zraa043","DOI":"10.1093\/bjsopen\/zraa043","article-title":"Combined APRI\/ALBI score to predict mortality after hepatic resection","volume":"5","author":"Starlinger","year":"2021","journal-title":"BJS Open"},{"key":"10.1016\/j.clcc.2022.09.002_bib0025","doi-asserted-by":"crossref","first-page":"237","DOI":"10.21037\/atm-20-3118","article-title":"Albumin-bilirubin index and platelet-albumin-bilirubin index contribute to identifying survival benefit candidates in patients with hepatocellular carcinoma and Child-Pugh grade A undergoing transcatheter arterial chemoembolization with sorafenib treatment","volume":"9","author":"Hu","year":"2021","journal-title":"Ann Transl Med"},{"key":"10.1016\/j.clcc.2022.09.002_bib0026","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.crad.2017.09.004","article-title":"Aspartate aminotransferase-to-platelet ratio predicts response to transarterial chemoembolisation and prognosis in hepatocellular carcinoma patients","volume":"73","author":"Tang","year":"2018","journal-title":"Clin Radiol"},{"key":"10.1016\/j.clcc.2022.09.002_bib0027","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.ijrobp.2005.12.051","article-title":"Resin 90Y-microsphere brachytherapy for unresectable colorectal liver metastases: modern USA experience","volume":"65","author":"Kennedy","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clcc.2022.09.002_bib0028","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1007\/s00270-009-9658-8","article-title":"Selective internal radiation therapy with SIR-spheres for the treatment of unresectable colorectal hepatic metastases","volume":"32","author":"Cianni","year":"2009","journal-title":"Cardiovasc Intervent Radiol"},{"key":"10.1016\/j.clcc.2022.09.002_bib0029","doi-asserted-by":"crossref","first-page":"665","DOI":"10.2967\/jnumed.115.166082","article-title":"90Y Radioembolization of Colorectal Hepatic Metastases Using Glass Microspheres: Safety and Survival Outcomes from a 531-Patient Multicenter Study","volume":"57","author":"Hickey","year":"2016","journal-title":"J Nucl Med"},{"key":"10.1016\/j.clcc.2022.09.002_bib0030","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1007\/s00270-020-02643-x","article-title":"Short-term safety and quality of life outcomes following radioembolization in primary and secondary liver tumours: a multi-centre analysis of 200 patients in France","volume":"44","author":"Loffroy","year":"2021","journal-title":"Cardiovasc Intervent Radiol"},{"key":"10.1016\/j.clcc.2022.09.002_bib0031","doi-asserted-by":"crossref","first-page":"486","DOI":"10.3109\/0284186X.2015.1101151","article-title":"Yttrium-90 radioembolization for the treatment of chemorefractory colorectal liver metastases: technical results, clinical outcome and factors potentially influencing survival","volume":"55","author":"Maleux","year":"2016","journal-title":"Acta Oncol"},{"key":"10.1016\/j.clcc.2022.09.002_bib0032","doi-asserted-by":"crossref","first-page":"639","DOI":"10.21037\/jgo-20-346","article-title":"Incidence and risk factors for sustained hepatic function toxicity 6 months after radioembolization: analysis of the radiation-emitting sir-spheres in non-resectable liver tumor (RESIN) registry","volume":"12","author":"Brown","year":"2021","journal-title":"J Gastrointest Oncol"},{"key":"10.1016\/j.clcc.2022.09.002_bib0033","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.clon.2018.09.002","article-title":"Analysis of a National Programme for Selective Internal Radiation Therapy for colorectal cancer liver metastases","volume":"31","author":"White","year":"2019","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"10.1016\/j.clcc.2022.09.002_bib0034","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1186\/s12885-016-2549-x","article-title":"Y90 Radioembolization in chemo-refractory metastastic, liver dominant colorectal cancer patients: outcome assessment applying a predictive scoring system","volume":"16","author":"Damm","year":"2016","journal-title":"BMC Cancer"},{"key":"10.1016\/j.clcc.2022.09.002_bib0035","first-page":"8","article-title":"Factors affecting oncologic outcomes of 90Y radioembolization of heavily pre-treated patients with colon cancer liver metastases","volume":"18","author":"Kurilova","year":"2019","journal-title":"Clin Colorectal Cancer"},{"issue":"5","key":"10.1016\/j.clcc.2022.09.002_bib0036","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1080\/17474124.2020.1748010","article-title":"ALBI versus child-pugh in predicting outcome of patients with HCC: a systematic review","volume":"14","author":"Peng","year":"2020","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.clcc.2022.09.002_bib0037","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/S1665-2681(19)31836-8","article-title":"AST to platelet ratio index (APRI) for the noninvasive evaluation of liver fibrosis","volume":"7","author":"Loaeza-del-Castillo","year":"2008","journal-title":"Ann Hepatol"},{"key":"10.1016\/j.clcc.2022.09.002_bib0038","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1002\/jso.24166","article-title":"Platelet count is more useful for predicting posthepatectomy liver failure at surgery for hepatocellular carcinoma than indocyanine green clearance test","volume":"113","author":"Tomimaru","year":"2016","journal-title":"J Surg Oncol"},{"key":"10.1016\/j.clcc.2022.09.002_bib0039","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1111\/liv.13317","article-title":"Thrombocytopenia in chronic liver disease","volume":"37","author":"Peck-Radosavljevic","year":"2017","journal-title":"Liver Int"},{"key":"10.1016\/j.clcc.2022.09.002_bib0040","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1200\/JCO.2014.57.9151","article-title":"Assessment of liver function in patients with hepatocellular carcinoma: a new evidence-based approach-the ALBI grade","volume":"33","author":"Johnson","year":"2015","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clcc.2022.09.002_bib0041","doi-asserted-by":"crossref","first-page":"840","DOI":"10.21037\/jgo.2018.05.14","article-title":"Using the Albumin-Bilirubin (ALBI) grade as a prognostic marker for radioembolization of hepatocellular carcinoma","volume":"9","author":"Mohammadi","year":"2018","journal-title":"J Gastrointest Oncol"},{"key":"10.1016\/j.clcc.2022.09.002_bib0042","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1007\/s00261-016-0875-8","article-title":"Connecting cancer biology and clinical outcomes to imaging in KRAS mutant and wild-type colorectal cancer liver tumors following selective internal radiation therapy with yttrium-90","volume":"42","author":"Magnetta","year":"2017","journal-title":"Abdom Radiol (NY)"},{"key":"10.1016\/j.clcc.2022.09.002_bib0043","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.2967\/jnumed.116.173104","article-title":"Partition Model-Based 99mTc-MAA SPECT\/CT predictive dosimetry compared with 90Y TOF PET\/CT posttreatment dosimetry in radioembolization of hepatocellular carcinoma: a quantitative agreement comparison","volume":"57","author":"Gnesin","year":"2016","journal-title":"J Nucl Med"},{"key":"10.1016\/j.clcc.2022.09.002_bib0044","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.2967\/jnumed.116.184713","article-title":"Resin Versus Glass microspheres for (90)Y transarterial radioembolization: comparing survival in unresectable hepatocellular carcinoma using pretreatment partition model dosimetry","volume":"58","author":"Van Der Gucht","year":"2017","journal-title":"J Nucl Med"},{"key":"10.1016\/j.clcc.2022.09.002_bib0045","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1148\/radiol.2020191606","article-title":"Relationship of tumor radiation-absorbed dose to survival and response in hepatocellular carcinoma treated with transarterial radioembolization with (90)Y in the SARAH study","volume":"296","author":"Hermann","year":"2020","journal-title":"Radiology"},{"key":"10.1016\/j.clcc.2022.09.002_bib0046","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S2468-1253(20)30290-9","article-title":"Personalised versus standard dosimetry approach of selective internal radiation therapy in patients with locally advanced hepatocellular carcinoma (DOSISPHERE-01): a randomised, multicentre, open-label phase 2 trial","volume":"6","author":"Garin","year":"2021","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.clcc.2022.09.002_bib0047","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.2967\/jnumed.120.255745","article-title":"Dose-Response and dose-toxicity relationships for glass (90)Y radioembolization in patients with liver metastases from colorectal cancer","volume":"62","author":"Alsultan","year":"2021","journal-title":"J Nucl Med"},{"key":"10.1016\/j.clcc.2022.09.002_bib0048","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/s13550-018-0419-z","article-title":"(90)Y-PET\/CT-based dosimetry after selective internal radiation therapy predicts outcome in patients with liver metastases from colorectal cancer","volume":"8","author":"Levillain","year":"2018","journal-title":"EJNMMI Res"},{"key":"10.1016\/j.clcc.2022.09.002_bib0049","first-page":"91","article-title":"An introduction to survival statistics: kaplan-meier analysis","volume":"7","author":"Dudley","year":"2016","journal-title":"J Adv Pract Oncol"}],"container-title":["Clinical Colorectal Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1533002822001001?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1533002822001001?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T23:08:23Z","timestamp":1761520103000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1533002822001001"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":49,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["S1533002822001001"],"URL":"https:\/\/doi.org\/10.1016\/j.clcc.2022.09.002","relation":{},"ISSN":["1533-0028"],"issn-type":[{"value":"1533-0028","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prognostic Factors for Effectiveness Outcomes After Transarterial Radioembolization in Metastatic Colorectal Cancer: Results From the Multicentre Observational Study CIRT","name":"articletitle","label":"Article Title"},{"value":"Clinical Colorectal Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clcc.2022.09.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}